Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 73 | Longs Won 37/70 52% | Profit Factor 1.84 |
| Profitability | Shorts Won 3/3 100% | Standard Deviation $11,141.74 |
| Average Win $9,348.86 | Best Trade (Sep 19) $41,565.93 | Sharpe Ratio -23.42 |
| Average Loss -$6,158.89 | Worst Trade (Feb 26) -$25,678.56 | Z-Score -0.63 (47.39%) |
| Commissions $0 | Avg. Trade Length 2m 1w 5d | Expectancy $2,338.5 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.1% | 0.61% | 2.84% | 10.77% | 34.91% |
| Consecutive Losing Trades | 44 | 40 | 35 | 31 | 26 | 22 | 18 | 13 | 9 | 4 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
LGND Ligand Pharmaceuticals Inc. | 467.35 | $148,902.94 | $137,741.19 | - | -$11,161.75 | -7.5% | -1.263% |